{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:04:11Z","timestamp":1782547451428,"version":"3.54.5"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Education and Training, Australian Research Council","award":["DE200100030"],"award-info":[{"award-number":["DE200100030"]}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["LE160100026"],"award-info":[{"award-number":["LE160100026"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Discovery Early Career Research Award programme","award":["DE200100030"],"award-info":[{"award-number":["DE200100030"]}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Keratoconjunctivitis sicca (KCS) is a common and important eye disease of dogs and has been associated with the administration of trimethoprim sulfonamide (TMS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Determine the prevalence of KCS after TMS treatment at a population level and describe risk factors for KCS development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Dogs evaluated in general veterinary practice in Australia with records in VetCompass Australia between 2012 and 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Natural language processing was used to detect dogs treated with TMS and to detect dogs that subsequently developed KCS. Cox proportional hazards modeling was performed to investigate risk factors such as drug dose, duration of treatment, and patient level characteristics (breed, age, sex).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2243 dogs were treated with TMS during the study period. Four definitive cases of KCS and an additional 35 cases of possible KCS were detected (prevalence 1.8%; 95% confidence interval [CI], 1.3-2.5%). Median duration of TMS treatment was 10\u00a0days for both cases (interquartile range [IQR], 7-17\u00a0days) and non-cases (IQR, 7-15\u00a0days). Median doses were 32 and 33\u00a0mg\/kg\/day for cases and non-cases, respectively. Trimethoprim sulfonamide dose and duration of treatment were not associated with KCS. Some breeds were over-represented and older dogs were more likely to be affected (hazard ratio [HR], 1.076; 95% CI, 1.005-1.152; P\u00a0=\u00a0.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and clinical importance<\/jats:title>\n                    <jats:p>Keratoconjunctivitis sicca is rare in dogs treated with TMS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jvimsj\/aalaf013","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T09:02:02Z","timestamp":1768986122000},"source":"Crossref","is-referenced-by-count":1,"title":["Retrospective cohort study on the development of keratoconjunctivitis sicca in dogs treated with trimethoprim sulfonamide: a VetCompass Australia study"],"prefix":"10.1093","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-7567","authenticated-orcid":false,"given":"Laura Y","family":"Hardefeldt","sequence":"first","affiliation":[{"name":"Asia-Pacific Centre for Animal Health and National Centre for Antimicrobial Stewardship, Melbourne Veterinary School, University of Melbourne , Parkville 3052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ri","family":"Scarborough","sequence":"additional","affiliation":[{"name":"Asia-Pacific Centre for Animal Health and National Centre for Antimicrobial Stewardship, Melbourne Veterinary School, University of Melbourne , Parkville 3052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-9254","authenticated-orcid":false,"given":"Brian","family":"Hur","sequence":"additional","affiliation":[{"name":"Asia-Pacific Centre for Animal Health and National Centre for Antimicrobial Stewardship, Melbourne Veterinary School, University of Melbourne , Parkville 3052 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"2026020706120050800_ref1","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/VMRR.S66705","article-title":"Immune-mediated keratoconjunctivitis sicca in dogs: current perspectives on management","volume":"6","author":"Dodi","year":"2015","journal-title":"Vet Med (Auckl)"},{"key":"2026020706120050800_ref2","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/jsap.13382","article-title":"Keratoconjunctivitis sicca in dogs under primary veterinary care in the UK: an epidemiological study","volume":"62","author":"O'Neill","year":"2021","journal-title":"J Small Anim Pract"},{"key":"2026020706120050800_ref3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1463-5224.2009.00665.x","article-title":"Breed predisposition to congenital alacrima in dogs","volume":"12","author":"Westermeyer","year":"2009","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1463-5224.2007.00551.x","article-title":"Severe, unilateral, unresponsive keratoconjunctivitis sicca in 16 juvenile Yorkshire terriers","volume":"10","author":"Herrera","year":"2007","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1748-5827.2006.00185.x","article-title":"Canine keratoconjunctivitis sicca: disease trends in a review of 229 cases","volume":"48","author":"Sanchez","year":"2007","journal-title":"J Small Anim Pract"},{"key":"2026020706120050800_ref6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.2460\/ajvr.1994.55.05.692","article-title":"Effects of experimentally induced hypothyroidism on the eye and ocular adnexa of dogs","volume":"55","author":"Miller","year":"1994","journal-title":"Am J Vet Res"},{"key":"2026020706120050800_ref7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1463-5224.2005.00389.x","article-title":"Keratoconjunctival effects of diabetes mellitus in dogs","volume":"8","author":"Cullen","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1463-5224.2009.00699.x","article-title":"Conjunctival effects of canine distemper virus-induced keratoconjunctivitis sicca","volume":"12","author":"Almeida","year":"2009","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref9","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1136\/vr.141.21.539","article-title":"A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by leishmania infantum","volume":"141","author":"Ciaramella","year":"1997","journal-title":"Vet Rec"},{"key":"2026020706120050800_ref10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vetpar.2005.05.017","article-title":"Characterization of lacrimal gland lesions and possible pathogenic mechanisms of keratoconjunctivitis sicca in dogs with leishmaniosis","volume":"133","author":"Naranjo","year":"2005","journal-title":"Vet Parasitol"},{"key":"2026020706120050800_ref11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1463-5224.2011.00968.x","article-title":"Canine neurogenic keratoconjunctivitis sicca: 11 cases (2006-2010)","volume":"15","author":"Matheis","year":"2012","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref12","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2460\/javma.1992.201.12.1861","article-title":"Clinical and histological evaluation of the prolapsed third eyelid gland in dogs","volume":"201","author":"Dugan","year":"1992","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706120050800_ref13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.5326\/15473317-35-3-240","article-title":"Prolapse of the gland of the third eyelid in dogs: a retrospective study of 89 cases (1980 to 1990)","volume":"29","author":"Morgan","year":"1993","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706120050800_ref14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.2460\/ajvr.1984.45.01.112","article-title":"Keratoconjunctivitis sicca: histopathologic study of nictitating membrane and lacrimal glands from 28 dogs","volume":"45","author":"Kaswan","year":"1984","journal-title":"Am J Vet Res"},{"key":"2026020706120050800_ref15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.2460\/ajvr.1985.46.02.376","article-title":"Keratoconjunctivitis sicca: immunological evaluation of 62 canine cases","volume":"46","author":"Kaswan","year":"1985","journal-title":"Am J Vet Res"},{"key":"2026020706120050800_ref16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2754\/avb200372020267","article-title":"Effect of anaesthetic premedication with medetomidine-buprenorphine on the aqueous tear production in dogs","volume":"72","author":"Soontornvipart","year":"2003","journal-title":"Acta Vet Brno"},{"key":"2026020706120050800_ref17","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2460\/javma.230.4.541","article-title":"Keratoconjunctivitis sicca associated with administration of etodolac in dogs: 211 cases (1992-2002)","volume":"230","author":"Klauss","year":"2007","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706120050800_ref18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1748-5827.2001.tb02490.x","article-title":"Treatment of partial seizures and seizure-like activity with felbamate in six dogs","volume":"42","author":"Ruehlmann","year":"2001","journal-title":"J Small Anim Pract"},{"key":"2026020706120050800_ref19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1751-0813.1978.tb05575.x","article-title":"Keratoconjunctivitis sicca in dogs associated with sulphonamide administration","volume":"54","author":"Slatter","year":"1978","journal-title":"Aust Vet J"},{"key":"2026020706120050800_ref20","doi-asserted-by":"publisher","first-page":"432","DOI":"10.2460\/javma.1982.180.04.432","article-title":"Keratoconjunctivitis sicca associated with sulfonamide therapy in dogs","volume":"180","author":"Morgan","year":"1982","journal-title":"J Am Vet Med Assoc"},{"key":"2026020706120050800_ref21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2460\/javma.1982.180.04.432","article-title":"Keratoconjunctivitis sicca in dogs associated with sulfonamide therapy: 16 cases (1980-1990)","volume":"1","author":"Diehl","year":"1992","journal-title":"Prog Vet Comp Ophthal"},{"key":"2026020706120050800_ref22","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1939-1676.2003.tb02495.x","article-title":"Clinical findings in 40 dogs with hypersensitivity associated with administration of potentiated sulfonamides","volume":"17","author":"Trepanier","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020706120050800_ref23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5326\/15473317-31-3-236","article-title":"A quantitative study of the effects of Tribrissen on canine tear production","volume":"31","author":"Berger","year":"1995","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706120050800_ref24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/vr.116.15.391","article-title":"Keratoconjunctivitis sicca in the dog associated with the administration of salicylazosulphapyridine (sulphasalazine)","volume":"116","author":"Sansom","year":"1985","journal-title":"Vet Rec"},{"key":"2026020706120050800_ref25","first-page":"93","article-title":"Interaction of age and gender on occurrence of canine keratoconjunctivitis sicca","volume":"1","author":"Kaswan","year":"1991","journal-title":"Prog Vet Comp Ophthal"},{"key":"2026020706120050800_ref26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1365-2885.2004.00576.x","article-title":"Idiosyncratic toxicity associated with potentiated sulfonamides in the dog","volume":"27","author":"Trepanier","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020706120050800_ref27","doi-asserted-by":"publisher","DOI":"10.1136\/VR.H6174"},{"key":"2026020706120050800_ref29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ani7100074","article-title":"VetCompass Australia: a national big data collection system for veterinary science","volume":"7","author":"McGreevy","year":"2017","journal-title":"Animals (Basel)"},{"key":"2026020706120050800_ref30","volume-title":"Proceedings of the BioNLP 2020 workshop","author":"Hur"},{"key":"2026020706120050800_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlab194","article-title":"Evaluating the dose, indication and agreement with guidelines of antimicrobial use in companion animal practice with natural language processing","volume":"4","author":"Hur","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"2026020706120050800_ref32","doi-asserted-by":"publisher","first-page":"e0230049","DOI":"10.1371\/journal.pone.0230049","article-title":"Describing the antimicrobial usage patterns of companion animal veterinary practices; free text analysis of more than 4.4 million consultation records","volume":"15","author":"Hur","year":"2020","journal-title":"PloS One"},{"key":"2026020706120050800_ref33","volume-title":"Is That the Right Dose?","author":"Hur","year":"2024"},{"key":"2026020706120050800_ref34","doi-asserted-by":"publisher","first-page":"e0182064","DOI":"10.1371\/journal.pone.0182064","article-title":"Growth standard charts for monitoring bodyweight in dogs of different sizes","volume":"12","author":"Salt","year":"2017","journal-title":"PloS One"},{"key":"2026020706120050800_ref35","article-title":"2025. ChatGPT[o3-mini]","author":"Open"},{"key":"2026020706120050800_ref36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1463-5224.2005.00390.x","article-title":"Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca","volume":"8","author":"Berdoulay","year":"2005","journal-title":"Vet Ophthalmol"},{"key":"2026020706120050800_ref37","author":"Asia Pacific Centre for Animal Health","year":"2017"},{"key":"2026020706120050800_ref38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/vr.98.5.82","article-title":"Studies in dogs and cats dosed with trimethoprim and sulphadiazine","volume":"98","author":"Craig","year":"1976","journal-title":"Vet Rec"},{"key":"2026020706120050800_ref39","first-page":"410","article-title":"Trimethoprim and sulfadiazine: adverse effects of long term administration in dogs","volume":"14","author":"Lording","year":"1978","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020706120050800_ref40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/01652176.1995.9694550","article-title":"A retrospective evaluation of adverse reactions to trimethoprim-sulphonamide combinations in dogs and cats","volume":"17","author":"Noli","year":"1995","journal-title":"Vet Q"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf013\/66458543\/aalaf013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/40\/1\/aalaf013\/66458543\/aalaf013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T11:12:13Z","timestamp":1770462733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/doi\/10.1093\/jvimsj\/aalaf013\/8429714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1093\/jvimsj\/aalaf013","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"aalaf013"}}